Cognitive and behavioral impact of antiseizure medications, neuromodulation, ketogenic diet, and surgery in Lennox-Gastaut syndrome: A comprehensive review
- 23 January 2025
- journal article
- review article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 164, 110272
Abstract
No abstract availableKeywords
This publication has 187 references indexed in Scilit:
- Clinical trials for Lennox–Gastaut syndrome: Challenges and prioritiesAnnals of Clinical and Translational Neurology, 2024
- Long‐term outcomes and adaptive behavior in adult patients with Lennox–Gastaut syndromeEpilepsia Open, 2024
- Practical considerations for the use of fenfluramine to manage patients with Dravet syndrome or Lennox–Gastaut syndrome in clinical practiceEpilepsia Open, 2024
- Pediatric neuromodulation for drug‐resistant epilepsy: Survey of current practices, techniques, and outcomes across US epilepsy centersEpilepsia Open, 2024
- Norwegian population‐based study of effectiveness of vagus nerve stimulation in patients with developmental and epileptic encephalopathiesEpilepsia Open, 2024
- Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut SyndromeJAMA Neurology, 2022
- Observational study of medical marijuana as a treatment for treatment‐resistant epilepsiesAnnals of Clinical and Translational Neurology, 2022
- Centromedian thalamic responsive neurostimulation for Lennox‐Gastaut epilepsy and autismAnnals of Clinical and Translational Neurology, 2020
- Ketogenic diet effects on 52 children with pharmacoresistant epileptic encephalopathy: A clinical prospective studyBrain and Behavior, 2018
- Anterior callosotomy in the treatment of medically intractable epilepsies: A study of 43 patients with a mean follow‐up of 39 monthsAnnals of Neurology, 1991